JP Morgan Upgrades InterMune To Overweight, Raises PT To $45

June 17, 2011 6:12 AM | 8 seconds read |
JP Morgan has upgraded InterMune ITMN from Neutral to Overweight and has raised the price target from $38 to $45.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: UpgradesPrice TargetAnalyst RatingsBiotechnologyHealth CareInterMuneJP Morgan
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!